FBRX (STOCKS)
Forte Biosciences, Inc. Common Stock
$31.394700
-3.695300 (-10.53%)
Prev close: $35.090000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Paul A. Wagner
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $427.68M
- Employees
- 17
- P/E (TTM)
- -6.70
- P/B (TTM)
- 7.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $2.72M |
| Benefits Costs and Expenses | $71.05M |
| Costs And Expenses | $71.05M |
| Nonoperating Income/Loss | $2.32M |
| Operating Expenses | $70.66M |
| Operating Income/Loss | -$70.66M |
| Income/Loss From Continuing Operations After Tax | -$69.38M |
| Income/Loss From Continuing Operations Before Tax | -$68.34M |
| Income Tax Expense/Benefit | $1.04M |
| Income Tax Expense/Benefit, Current | $1.04M |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Interest Income/Expense After Provision For Losses | $2.72M |
| Interest Income/Expense Operating, Net | $2.72M |
| Net Income/Loss | -$69.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$69.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$69.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$4.71 |
| Diluted Earnings Per Share | -$4.71 |
| Assets | $82.78M |
| Current Assets | $80.59M |
| Noncurrent Assets | $2.19M |
| Fixed Assets | $129.00K |
| Other Non-current Assets | $2.06M |
| Liabilities | $21.79M |
| Current Liabilities | $20.75M |
| Accounts Payable | $9.99M |
| Other Current Liabilities | $10.76M |
| Noncurrent Liabilities | $1.04M |
| Equity | $60.99M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $60.99M |
| Liabilities And Equity | $82.78M |
| Net Cash Flow From Operating Activities | -$50.88M |
| Net Cash Flow From Operating Activities, Continuing | -$50.88M |
| Net Cash Flow From Investing Activities | $36.23M |
| Net Cash Flow From Investing Activities, Continuing | $36.23M |
| Net Cash Flow From Financing Activities | $69.36M |
| Net Cash Flow From Financing Activities, Continuing | $69.36M |
| Net Cash Flow | $54.71M |
| Net Cash Flow, Continuing | $54.71M |
| Comprehensive Income/Loss | -$69.38M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$69.38M |
| Other Comprehensive Income/Loss | -$8.00K |